Chengdu Pukang Biotechnology Co., Ltd

Chengdu Pukang Biotechnology Co., Ltd is specializing in the long-term development of peptide drugs for chronic disease. As a manufacturer, it integrates production, sales, research and development. At present, our company has a research and development center of 2400 square meters, and a production workshop of 1000 square meters. It plans to build a production base of 60,000 square meters carring out quality system management according to GMP standards. The Corporation's main product are high purity single molecular PEG series derivatives, hydroxyproline series derivatives, polypeptide long acting drug side chain and its intermediates (including Semaglutide side chain, liraglutide side chain, Degu insulin side chain, long-acting production hormone, etc.), and short peptide drugs modified side chains (semaglutide dipeptide, tetrapeptide). Our company is working with innovative pharmaceutical companies to build a platform for research and development of polypeptide long-acting drugs, and is committed to building a systematic and diverse long-acting side chain library, establishing molecular blocks of polypeptide long-acting side chains, and providing various development solutions for customers to develop polypeptide long-acting drugs. Our company adheres to the concept of "quality first, technology foremost", to provide global customers with the best products and the best service.